Company Filing History:
Years Active: 1995
Title: Inventor Thomas C. Herzig: Innovating Enantiomerically-Pure Compounds
Introduction
Thomas C. Herzig, based in Oberentfelden, Switzerland, is a devoted inventor with a significant contribution to the field of organic chemistry. His innovative efforts have culminated in the development of a unique method for preparing enantiomerically-pure compounds, showcasing his expertise and dedication to advancing scientific knowledge.
Latest Patents
Herzig holds one notable patent titled "Method of preparing enantiomerically-pure 3-methyl-5-(1-(C.sub.1 -C.sub.3 -alkyl)-2-pyrrolidinyl)isoxazole." This novel process enables the preparation of enantiomerically-pure compounds in high yield through a series of chemical reactions involving protected pyrrolidine or 2-oxo-pyrrolidine starting materials. The methodology involves reacting these materials with a suitable organic anion to create a beta-keto oxime intermediate, which is subsequently cyclized and dehydrated. Additionally, the patent outlines various intermediates useful in the preparation of these compounds.
Career Highlights
Thomas C. Herzig is employed by Abbott Laboratories Corporation, a renowned company in the healthcare and pharmaceutical industries. His role involves rigorous research and development, contributing significantly to the company’s portfolio of innovative solutions. Herzig’s dedication to his work has made a lasting impact on the broader scientific community.
Collaborations
Throughout his career, Thomas has collaborated with esteemed colleagues, including Nan-Horng Lin and Yun He. These partnerships reflect a commitment to teamwork and the sharing of knowledge, which are essential elements in driving innovation and achieving successful outcomes in research.
Conclusion
In summary, Thomas C. Herzig stands out as an inventive force in the realm of organic chemistry. With his patented methods for producing enantiomerically-pure compounds, he continues to contribute valuable insights to the scientific community. His collaborations and role at Abbott Laboratories Corporation further solidify his position as an influential inventor dedicated to advancing innovation in pharmaceutical chemistry.